Members |
targetComponentId |
obekant miljö |
Unfamiliar environment (finding) |
ovänlig miljö |
Unfriendly environment |
negativ miljö |
Unhappy environment (finding) |
unilateral lobektomi av sköldkörteln |
Subtotal thyroidectomy |
ensidig facial pares |
Facial hemiparesis |
ensidig huvudvärk |
Unilateral headache |
unilateralt nevusliknande telangiektasisyndrom |
Unilateral nevoid telangiectasia |
kortvarig, ensidig, neuralgiartad smärta med konjunktival injektion och tårbildningssyndrom |
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing syndrome (disorder) |
oavsiktlig endobronkial intubation |
Unintended insertion of endotracheal tube into bronchus |
den presenterade enhetens storleksmått |
Unit of presentation size quantity |
Unlisted biofeedback training |
Biofeedback procedure |
Unlisted hazard |
Physical hazard |
Unlisted psychologic test, explain by report |
Psychologic test |
Unlisted reconstruction of thumb |
Reconstruction of thumb |
Unlisted traumatic agent |
Traumatic agent |
Unspecified accidents |
Accidental event (event) |
Unspecified aneurysm |
Vascular disorder |
Unspecified atresia |
Congenital disease (disorder) |
Unspecified circumscribed scleroderma |
Localised scleroderma |
Unspecified defect |
Disease |
Unspecified destructive substance |
Substance |
Unspecified device or implant |
Device |
Unspecified diagnostic cystoscopy and biopsy of bladder lesion |
Cystoscopy and biopsy of lesion of bladder (procedure) |
Unspecified disseminated chorioretinitis |
Disseminated chorioretinitis |
Unspecified fistula |
Fistula |
Unspecified hernia |
Disease |
Unspecified illegal abortion NOS |
Termination of pregnancy |
Unspecified illegal abortion with complication NOS |
Induced termination of pregnancy (procedure) |
Unspecified illegal abortion with damage to pelvic organs or tissues |
Induced termination of pregnancy complicated by damage to pelvic organs and/or tissues (disorder) |
Unspecified illegal abortion with delayed or excessive hemorrhage |
Excessive hemorrhage due to and following induced termination of pregnancy (disorder) |
Unspecified illegal abortion with embolism |
Induced termination of pregnancy complicated by embolism (disorder) |
Unspecified illegal abortion with genital tract or pelvic infection |
Induced termination of pregnancy complicated by genital-pelvic infection (disorder) |
Unspecified illegal abortion with metabolic disorder |
Induced termination of pregnancy complicated by metabolic disorder (disorder) |
Unspecified illegal abortion with no mention of complication |
Induced termination of pregnancy (procedure) |
Unspecified illegal abortion with other specified complication |
Induced termination of pregnancy (procedure) |
Unspecified illegal abortion with renal failure |
Induced termination of pregnancy complicated by renal failure (disorder) |
Unspecified illegal abortion with shock |
Induced termination of pregnancy complicated by shock |
Unspecified injury of lung |
Injury of lung |
Unspecified legal abortion NOS |
Induced termination of pregnancy (procedure) |
Unspecified legal abortion with complication NOS |
Disorder following induced termination of pregnancy (disorder) |
Unspecified legal abortion with damage to pelvic organs or tissues |
Induced termination of pregnancy complicated by damage to pelvic organs and/or tissues (disorder) |
Unspecified legal abortion with delayed or excessive hemorrhage |
Excessive hemorrhage due to and following induced termination of pregnancy (disorder) |
Unspecified legal abortion with embolism |
Induced termination of pregnancy complicated by embolism (disorder) |
Unspecified legal abortion with genital tract or pelvic infection |
Induced termination of pregnancy complicated by genital-pelvic infection (disorder) |
Unspecified legal abortion with metabolic disorder |
Disorder following induced termination of pregnancy (disorder) |
Unspecified legal abortion with other specified complication |
Disorder following induced termination of pregnancy (disorder) |
Unspecified legal abortion with renal failure |
Induced termination of pregnancy complicated by renal failure (disorder) |
Unspecified legal abortion with shock |
Induced termination of pregnancy complicated by shock |
Unspecified maternal pyrexia during labor - delivered |
Disorder of labor / delivery |
Unspecified maternal pyrexia during labor NOS |
Disorder of labor / delivery |
Unspecified maternal pyrexia during labor with antenatal problem |
Disorder of labor / delivery |
Unspecified maternal pyrexia during labor, unspecified |
Disorder of labor / delivery |
Unspecified musculoskeletal disorder of the neck |
Musculoskeletal disorder of the neck |
Unspecified musculoskeletal disorder of the neck (disorder) |
Disorder of shoulder region (disorder) |
Unspecified open-angle glaucoma |
Open-angle glaucoma |
Unspecified puerperal psychosis |
Postpartum psychosis |
Unspecified radioactive substance |
Substance |
Unspecified stenosis |
Disease |
Unspecified substance |
Substance |
Unspecified surgical disorder |
Disease |
Unspecified thickness burn |
Burn |
Unsuccessful attempt to induce labor |
Failed induction of labor |
fynd som rör TNM-stadieindelning av tumör i matspjälkningsorganens eller luftvägarnas övre delar |
American Joint Committee on Cancer allowable value |
överarmslambå |
Flap (substance) |
icke kärlsäkrad överarmslambå |
Random pattern flap |
överarmslambå enligt Tagliocozzi |
Flap (substance) |
armlambå |
Flap (substance) |
övre ficklambå |
Flap (substance) |
Urea 40-50% injection |
Urea only product in parenteral dose form |
urea 40-50 %, injektionsvätska, lösning, flaska |
Urea only product in parenteral dose form |
allergi mot krämer innehållande karbamid |
Allergy to urea (finding) |
^14^C-märkt urea, 1 microcurie per kapsel |
Product containing carbon (13-C) urea in oral dose form (medicinal product form) |
^13^C-märkt urea 100 mg, pulver till oral lösning |
Product containing carbon (13-C) urea in oral dose form (medicinal product form) |
^13^C-märkt urea 100 mg, pulver till oral lösning + testkit |
Product containing carbon (13-C) urea in oral dose form (medicinal product form) |
^13^C-märkt urea 100 mg, löslig tablett |
Product containing carbon (13-C) urea in oral dose form (medicinal product form) |
^13^C-märkt urea 125 mg, pulver till oral lösning |
Product containing carbon (13-C) urea in oral dose form (medicinal product form) |
^13^C-märkt urea 75 mg, pulver till oral lösning |
Product containing carbon (13-C) urea in oral dose form (medicinal product form) |
^13^C-märkt urea 75 mg, pulver till oral lösning + kit |
Product containing carbon (13-C) urea in oral dose form (medicinal product form) |
Ureterectomy |
Ureterectomy |
Ureteroscopy |
Ureteroscopy (procedure) |
Ureteroscopy: [diagnostic NOS] or [NEC] |
Ureteroscopy (procedure) |
Urethral discharge symptom |
Urethral discharge |
symtom på flytning från uretra |
Urethral discharge |
Urethrolithotomy |
Removal of calculus of urethra with incision |
antiinfektivt medel för urinvägar |
Anti-infective agent (substance) |
fynd som rör TNM-stadieindelning av tumör i urinblåsa, uretär eller njurbäcken. |
American Joint Committee on Cancer allowable value |
Urinary cystostomy |
Suprapubic cystostomy |
Urine culture - Bacteria OS |
Microbial culture |
urinodling, bakterier specificerade på annat sätt |
Microbial culture |
urinmikroskopi avseende leukocyter och procentandel lymfocyter |
Urine microscopy for percentage of lymphocytes (procedure) |
urinmikroskopi avseende leukocyter och procentandel polymorfkärniga leukocyter |
Urine microscopy for percentage of polymorphonuclear leukocytes |
Urine microscopy: no cells |
No cells seen in urine via microscopy |
urinmikroskopi: ingen förekomst av celler |
No cells seen in urine via microscopy |
urinmikroskopi: ingen förekomst av epitelceller |
No epithelial cells seen in urine via microscopy (finding) |
urinmikroskopi: ingen förekomst av leukocyter |
No leukocytes seen in urine via microscopy |
Urine reducing substances NOS |
Reducing substances detected in urine (finding) |
Urine reducing substances NOS |
Reducing substances detected in urine (finding) |
Urine volume |
Urine volume measurement finding (finding) |
urobilinogenemi |
Urobilinogen level above reference range (finding) |
urofollitropin 150 enheter, pulver och vätska till injektionslösning, ampull |
Product containing only urofollitropin (medicinal product) |
urofollitropin 150 enheter, pulver till injektionsvätska, lösning, ampull |
Product containing only urofollitropin (medicinal product) |